Dr. Jeffrey Safran helps life sciences, biotechnology, diagnostics, and chemical companies develop, protect, and manage intellectual property portfolios around complex technologies. His practice spans patent prosecution and portfolio development, freedom-to-operate and other opinion work, licensing and commercialization, due diligence, and intellectual property aspects of business transactions. He develops and manages U.S. and international patent portfolios and counsels clients on strategies for protecting their technologies as they evolve and enter new applications and markets.
Jeff’s life sciences practice encompasses biotechnology, pharmaceuticals, biologics, antibodies and other binding proteins, immunology, gene editing, nucleic-acid technologies, diagnostic technologies, pharmaceutical formulations, and methods of treatment. His matter experience also includes patent work involving gene regulation and gene-editing technologies, therapeutic targets, delivery technologies, diagnostic approaches, and biologic and pharmaceutical innovations.
His practice also extends across chemistry and related commercial applications. Jeff has worked on intellectual property involving small molecules, polymers, specialty formulations, personal-care and cosmetic products, food and flavor applications, coatings, industrial fluids, and other chemical technologies. He also advises on diagnostic and food-safety technologies, including molecular and microbiological detection, PCR-based technologies, sample preparation and collection, and detection and instrumentation technologies.
Jeff also advises clients on intellectual property licensing and transactions, including in-licensing and out-licensing, company-to-company licensing, joint venture licensing, industry and university collaborations, and the intellectual property aspects of acquisitions and other business transactions. He also handles trademark prosecution and portfolio matters, including domestic and international brand protection.
